IL6 and Alzheimer disease: Folic acid (400–800 μg/day for 6 months) demonstrated cognitive benefits and reduced inflammation markers (IL-6, tumor necrosis factor alpha (TNF-α), Aβ-42) [61,62,63], highlighting its potential for AD treatment [62,64].